Atreca Shares Outstanding

BCEL
 Stock
  

USD 1.57  0.01  0.63%   

Atreca Inc Cl fundamentals help investors to digest information that contributes to Atreca Inc's financial success or failures. It also enables traders to predict the movement of Atreca Stock. The fundamental analysis module provides a way to measure Atreca Inc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atreca Inc stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Atreca Shares Outstanding Analysis

Atreca Inc's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Shares Outstanding 
 = 
Public Shares 
Repurchased 
More About Shares Outstanding | All Equity Analysis

Current Atreca Inc Shares Outstanding

    
  30.44 M  
Most of Atreca Inc's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atreca Inc Cl is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Compare to competition

Based on the latest financial disclosure, Atreca Inc Cl has 30.44 M of shares currently outstending. This is 83.14% lower than that of the Healthcare sector and 71.51% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 94.68% higher than that of the company.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Atreca Fundamentals

About Atreca Inc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Atreca Inc Cl's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atreca Inc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atreca Inc Cl based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 134 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Atreca Inc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamentals Comparison Now

   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module
Continue to Atreca Inc Piotroski F Score and Atreca Inc Altman Z Score analysis. Note that the Atreca Inc Cl information on this page should be used as a complementary analysis to other Atreca Inc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Atreca Stock analysis

When running Atreca Inc Cl price analysis, check to measure Atreca Inc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atreca Inc is operating at the current time. Most of Atreca Inc's value examination focuses on studying past and present price action to predict the probability of Atreca Inc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atreca Inc's price. Additionally, you may evaluate how the addition of Atreca Inc to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Is Atreca Inc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atreca Inc. If investors know Atreca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atreca Inc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Atreca Inc Cl is measured differently than its book value, which is the value of Atreca that is recorded on the company's balance sheet. Investors also form their own opinion of Atreca Inc's value that differs from its market value or its book value, called intrinsic value, which is Atreca Inc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atreca Inc's market value can be influenced by many factors that don't directly affect Atreca Inc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atreca Inc's value and its price as these two are different measures arrived at by different means. Investors typically determine Atreca Inc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atreca Inc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.